Case File №
#VI-2026-0089
Heman Peptide HM
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | A Great | 4 | 8.4 | 7.8 | 10.0 | 23 Oct 2025 |
| Tirzepatide | D Poor | 6 | 6.2 | 3.3 | 9.7 | 7 Oct 2025 |
| Retatrutide | E Bad | 19 | 6.8 | 2.9 | 9.8 | 23 Oct 2025 |
| Adamax | X N/A | 2 | 7.7 | 7.6 | 7.7 | 26 Jan 2026 |
| AICAR | X N/A | 1 | 6.9 | 6.9 | 6.9 | 6 May 2025 |
| ARA-290 | X N/A | 2 | 8.7 | 8.2 | 9.2 | 21 May 2026 |
| Aromasin (Exemestane) | X N/A | 1 | 6.8 | 6.8 | 6.8 | 20 Jun 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 7.8 | 7.8 | 7.8 | 13 Feb 2025 |
| BPC-157 Capsule | X N/A | 2 | 7.4 | 7.4 | 7.4 | 24 May 2026 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 4.9 | 4.9 | 4.9 | 7 May 2025 |
| Cartalax | X N/A | 1 | 6.3 | 6.3 | 6.3 | 27 Feb 2025 |
| Chonluten | X N/A | 2 | 5.9 | 5.8 | 6.1 | 25 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 7.4 | 7.4 | 7.4 | 27 Feb 2025 |
| DHT (Stanolone) | X N/A | 2 | 6.0 | 4.8 | 7.3 | 17 May 2026 |
| GW-501516 (Cardarine) | X N/A | 1 | 5.9 | 5.9 | 5.9 | 17 Dec 2024 |
| Halotestin (Fluoxymesterone) | X N/A | 2 | 6.5 | 6.0 | 7.0 | 17 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 6.5 | 6.5 | 6.5 | 3 Jul 2025 |
| KPV Oral | X N/A | 2 | 8.6 | 7.2 | 10.0 | 25 May 2026 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 7.9 | 7.9 | 7.9 | 17 Dec 2024 |
| MGF | X N/A | 1 | 5.0 | 5.0 | 5.0 | 11 Jun 2025 |
| NAD+ | X N/A | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 |
| Ovagen | X N/A | 2 | 5.2 | 4.0 | 6.4 | 26 Jan 2026 |
| Oxytocin Acetate | X N/A | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 |
| P21 | X N/A | 1 | 4.3 | 4.3 | 4.3 | 27 Feb 2025 |
| Primobolan E | X N/A | 2 | 6.2 | 4.4 | 8.1 | 21 May 2026 |
| Prostamax | X N/A | 1 | 7.9 | 7.9 | 7.9 | 14 Jan 2025 |
| PTD-DBM | X N/A | 1 | 6.1 | 6.1 | 6.1 | 7 May 2025 |
| RAD140 | X N/A | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 2 | 7.8 | 6.2 | 9.4 | 26 Jan 2026 |
| Semax | X N/A | 2 | 6.3 | 4.0 | 8.6 | 23 May 2026 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 2 | 7.0 | 5.9 | 8.1 | 24 May 2026 |
| Superdrol Oil | X N/A | 2 | 4.3 | 3.6 | 5.1 | 17 May 2026 |
| Tamoxifen (Nolvadex) Raw | X N/A | 1 | 8.1 | 8.1 | 8.1 | 11 Jun 2025 |
| Test Suspension | X N/A | 2 | 6.8 | 6.5 | 7.0 | 21 May 2026 |
| Thymalin | X N/A | 1 | 4.5 | 4.5 | 4.5 | 13 Feb 2025 |
| Tren Hex Raw | X N/A | 1 | 6.3 | 6.3 | 6.3 | 3 Jul 2025 |
| Vesugen | X N/A | 2 | 8.4 | 6.9 | 9.8 | 19 Jan 2026 |
| Vilon | X N/A | 2 | 7.0 | 6.4 | 7.5 | 21 May 2026 |
| Vitamin B12 1mg/ml | X N/A | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 |
Exhibit II
Evidence Log
59 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Tirzepatide | 4.4 D | 30mg | 14.5mg | -51.7% | 99.80% | n/a | No Label / Copper Crimp / Clear Cap | Lab G |
| 25 May 2026 | Retatrutide | 7.3 A | 10mg | 10.5mg | +5.0% | 99.60% | n/a | No Label / Copper Crimp / Clear Cap | Lab G |
| 25 May 2026 | Retatrutide | 7.0 A | 30mg | 31.1mg | +3.7% | 99.50% | n/a | No Label / Silver Crimp / Green Cap | Lab G |
| 25 May 2026 | Retatrutide | 6.0 B | 20mg | 17.8mg | -11.0% | 99.80% | n/a | No Label / Silver Crimp / Clear Blue Cap | Lab G |
| 25 May 2026 | Chonluten | 7.2 A | 5mg | 4.4mg | -12.0% | 95.14% | t49z4u | Lab C | Public |
| 25 May 2026 | Halotestin (Fluoxymesterone) | 6.2 A | 20mg | 20.4mg | +2.2% | 95.70% | bqno6p | Lab G | Public |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.0 A | 5mg | 5.2mg | +4.5% | 99.96% | 8o1pc7 | Lab C | Community |
| 24 May 2026 | Retatrutide | 8.0 A | 10mg | 10.5mg | +5.0% | 99.90% | below LOQ | No Label / Silver Crimp / Green Cap | Lab E |
| 24 May 2026 | Adamax | 8.0 A | 15mg | 17.9mg | +19.3% | 98.16% | 750ixy | Lab A | Public |
| 24 May 2026 | ARA-290 | 9.6 A | 5mg | 5.2mg | +3.4% | 95.58% | 2y3mfm | Lab E | Public |
| 24 May 2026 | Chonluten | 4.0 C | 10mg | 10.2mg | +2.0% | 95.57% | 59zd2u | Lab A | Public |
| 24 May 2026 | Ovagen | 6.3 A | 15mg | 17.7mg | +18.2% | 95.42% | lpr923 | Lab B | Community |
| 24 May 2026 | Ovagen | 4.4 C | 30mg | 27.6mg | -7.9% | 96.11% | 3ndawu | Lab G | Public |
| 24 May 2026 | Oxytocin Acetate | 6.5 A | 10mg | 10.0mg | +0.4% | 98.78% | yyst2j | Lab F | Public |
| 24 May 2026 | Aromasin (Exemestane) | 4.8 C | 50mg | 47.2mg | -5.5% | 99.88% | smaqgz | Lab E | Community |
| 24 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 7.3 A | 200mg/ml | 231.0mg/ml | +15.5% | 99.04% | 3rgrw0 | Lab D | Community |
| 23 May 2026 | Cartalax | 9.6 A | 15mg | 17.5mg | +16.5% | 95.09% | 7bnzfa | Lab C | Community |
| 23 May 2026 | Semax | 8.9 A | 50mg | 61.7mg | +23.4% | 98.75% | vqsqe4 | Lab B | Community |
| 21 May 2026 | ARA-290 | 8.2 A | 20mg | 23.1mg | +15.3% | 97.43% | d46biz | Lab E | Public |
| 21 May 2026 | Retatrutide | 8.0 A | 50mg | 48.1mg | -3.8% | 99.90% | n/a | (no data) | Lab E |
| 21 May 2026 | Tirzepatide | 9.7 A | 10mg | 10.6mg | +6.0% | 99.90% | n/a | No Label / Silver Crimp / White Cap | Lab E |
| 21 May 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 6.0 A | 25mg | 29.6mg | +18.5% | 97.12% | s8artt | Lab C | Public |
| 21 May 2026 | Tren Hex Raw | 8.4 A | 1g | 1.2g | +16.6% | 98.50% | hdksks | Lab E | Public |
| 21 May 2026 | Vilon | 7.5 A | 5mg | 4.4mg | -12.8% | 97.26% | 6xztp6 | Lab D | Public |
| 20 May 2026 | P21 | 4.0 C | 10mg | 9.6mg | -4.2% | 96.12% | x5kodx | Lab G | Public |
| 19 May 2026 | BPC-157 Capsule | 8.2 A | 10mg | 10.1mg | +1.3% | 97.29% | 1vyu2r | Lab B | Public |
| 19 May 2026 | MGF | 4.3 C | 10mg | 8.9mg | -11.3% | 97.35% | e2sa5m | Lab G | Public |
| 19 May 2026 | Tamoxifen (Nolvadex) Raw | 7.5 A | 500g | 588.6g | +17.7% | 96.75% | li26mf | Lab G | Public |
| 17 May 2026 | Test Suspension | 6.8 A | 300mg/ml | 316.3mg/ml | +5.4% | 96.60% | yw9b5o | Lab F | Community |
| 29 Jan 2026 | Test Suspension | 6.0 A | 300mg/ml | 283.7mg/ml | -5.4% | 97.16% | mdfiu9 | Lab E | Public |
| 29 Jan 2026 | Vilon | 7.2 A | 50mg | 43.3mg | -13.4% | 98.25% | ql3iye | Lab D | Community |
| 19 Jan 2026 | GW-501516 (Cardarine) | 5.1 B | 100mg | 102.0mg | +2.0% | 95.08% | 0av740 | Lab E | Community |
| 19 Jan 2026 | RAD140 | 4.0 C | 20mg | 22.6mg | +13.2% | 95.60% | 7nri9i | Lab E | Public |
| 9 Jan 2026 | Blend 300 (TRA/Mast P/Test P) | 8.2 A | 100mg/ml | 103.1mg/ml | +3.1% | 96.78% | jtc695 | Lab A | Public |
| 9 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.9 C | 50mg | 59.8mg | +19.5% | 98.32% | v77454 | Lab B | Public |
| 7 Jan 2026 | KPV Oral | 7.1 A | 25mg | 23.6mg | -5.4% | 98.45% | jsvr4c | Lab F | Public |
| 6 Jan 2026 | KPV Oral | 7.3 A | 10mg | 8.5mg | -15.0% | 99.67% | axq8yi | Lab A | Community |
| 6 Jan 2026 | NAD+ | 6.0 A | 5mg | 6.1mg | +21.6% | 95.62% | ngp3fd | Lab C | Public |
| 6 Jan 2026 | Primobolan E | 4.2 C | 300mg/ml | 290.0mg/ml | -3.3% | 95.37% | pnl70w | Lab E | Public |
| 6 Jan 2026 | Vesugen | 8.3 A | 30mg | 35.7mg | +18.9% | 95.43% | fiixdu | Lab F | Public |
| 29 Dec 2025 | BPC-157 Capsule | 6.6 A | 20mg | 17.2mg | -14.2% | 99.34% | g9fefm | Lab F | Public |
| 29 Dec 2025 | Prostamax | 7.9 A | 30mg | 35.9mg | +19.8% | 95.71% | u5icfr | Lab A | Public |
| 5 Dec 2025 | DHT (Stanolone) | 4.1 C | 100mg/ml | 90.1mg/ml | -9.9% | 95.70% | fa418b | Lab B | Public |
| 5 Dec 2025 | RIPEX 225 (TRA/Mast P/Test P) | 7.0 A | 300mg/ml | 305.5mg/ml | +1.8% | 98.50% | t4feop | Lab D | Public |
| 5 Dec 2025 | Semax | 6.5 A | 5mg | 4.3mg | -13.6% | 97.60% | 4ry9qd | Lab D | Public |
| 5 Dec 2025 | Superdrol Oil | 5.2 B | 100mg/ml | 86.8mg/ml | -13.2% | 99.94% | 3b36t5 | Lab E | Public |
| 5 Dec 2025 | Thymalin | 5.0 B | 20mg | 24.0mg | +19.9% | 95.43% | 6kk6am | Lab A | Public |
| 23 Nov 2025 | Adamax | 6.5 A | 20mg | 19.6mg | -2.2% | 98.35% | irsni7 | Lab C | Public |
| 17 Nov 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 7.0 A | 50mg | 58.2mg | +16.3% | 99.97% | c96587 | Lab G | Public |
| 5 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 5.8 B | 20mg | 20.0mg | +0.0% | 97.82% | rk8al7 | Lab G | Community |
| 4 Nov 2025 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 9.5 A | 200mg/ml | 217.1mg/ml | +8.6% | 96.76% | 83m7j3 | Lab E | Public |
| 4 Nov 2025 | Primobolan E | 7.8 A | 250mg/ml | 292.9mg/ml | +17.2% | 96.59% | tgd10d | Lab A | Public |
| 4 Nov 2025 | Superdrol Oil | 5.2 B | 100mg/ml | 102.3mg/ml | +2.3% | 98.01% | 96sm4q | Lab E | Community |
| 4 Nov 2025 | Vitamin B12 1mg/ml | 8.1 A | 100mg/ml | 86.1mg/ml | -13.9% | 99.57% | xvwwqu | Lab F | Public |
| 17 Oct 2025 | AICAR | 7.8 A | 5mg | 5.4mg | +8.2% | 97.84% | u5r3g6 | Lab E | Public |
| 17 Oct 2025 | PTD-DBM | 5.4 B | 15mg | 14.2mg | -5.2% | 97.85% | bnh5s1 | Lab C | Community |
| 17 Oct 2025 | Vesugen | 8.2 A | 10mg | 11.8mg | +18.3% | 97.65% | addsne | Lab A | Public |
| 9 Oct 2025 | Halotestin (Fluoxymesterone) | 7.6 A | 100mg | 109.4mg | +9.4% | 99.83% | c45v9k | Lab B | Community |
| 3 Oct 2025 | DHT (Stanolone) | 4.0 C | 250mg/ml | 304.4mg/ml | +21.7% | 98.46% | wzlb7w | Lab F | Community |
— END OF EVIDENCE LOG —